Ambu A/S (OTCMKTS:AMBBY) Sets New 1-Year Low – What’s Next?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY)’s stock price hit a new 52-week low during trading on Monday . The stock traded as low as $12.54 and last traded at $12.54, with a volume of 307 shares changing hands. The stock had previously closed at $12.61.

Ambu A/S Trading Down 2.3%

The company’s 50 day simple moving average is $13.54 and its 200-day simple moving average is $14.37. The firm has a market cap of $2.95 billion, a P/E ratio of 40.45 and a beta of 0.93. The company has a quick ratio of 1.67, a current ratio of 2.86 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.The firm had revenue of $242.85 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.